Efficacy and Safety of Aflibercept 8 mg in PULSAR Trial in Neovascular AMD

Opinion
Video

Dr. Marion Munk reviews the Phase 3 clinical trial of high-dose aflibercept (8 mg) in neovascular AMD, emphasizing how this new therapy could alleviate the treatment burden for patients while providing superior outcomes.

Related Videos
Giulia Corradetti, MD, discusses her presentation "Functional Microperimetric Correlates of OCT Structures Features in Intermediate AMD"
Marion Munk, MD, PhD, presenting slides
Ash Abbey, MD, shares 36-month data from the GALE study of pegcetacoplan
Antonio Filipe Macedo, OD, MSc, PhD, speaks about the 2024 ARVO meeting
Kasperi Kankare at the iCare booth at ESCRS
Megan Baldwin, PhD, CEO and managing director of Opthea Limited, speaking at ASRS 2023.
Related Content
Syringes of various sizes, stored in a clinic. Image credit: ©Sergey Ryzhov – stock.adobe.com

Outlook Therapeutics submits UK Marketing Authorisation Application for wet AMD treatment

May 13th 2024
Article

The submission for bevacizumab gamma (ONS-5010/LYTENAVA) follows a positive opinion from the CHMP in March

Susana Chung, OD, PhD, talks about her ARVO presentation titled "How similar is reading with central vision loss to reading in normal peripheral vision?"

ARVO 2024: New research indicates the need for a new approach to central vision loss

May 5th 2024
Article

Susana Chung, OD, PhD, speaks about one of her ARVO presentations and the future of artificial intelligence in eye care

An elderly woman undergoes an eye exam. Image credit: ©cherryandbees – stock.adobe.com

I-SCREEN programme will use AI and OCT imaging to identify and monitor AMD

April 17th 2024
Article

I-SCREEN will bring together 12 institutions across Europe, including Queen’s University Belfast

A hand writes a red check mark into a box on a white background. Image credit: ©Mihail – stock.adobe.com

Outlook Therapeutics receives positive CHMP opinion for bevacizumab for wet age-related macular degeneration

March 22nd 2024
Article

The European Commission is expected to make a decision about the application before the end of June

A no smoking sign hanging on a wall. ©stock.adobe.com – generated with Firefly AI

Smokers more likely to experience vision loss

March 13th 2024
Article

Research indicates smoking increases risk of AMD, cataracts and glaucoma

A line drawing of a human heart with an eye enclosed in its chambers. Image credit: ©croisy – stock.adobe.com

Listening to the heart: Lessons from cardiology in remote monitoring and AI

February 14th 2024
Article

Physicians explore how other specialties adopt and integrate remote monitoring

© 2024 MJH Life Sciences

All rights reserved.